Save time and get answers to complex questions with AI chat
Dabrafenib btd date 2023?Is guselkumab off patent in u s?Mobic injection patent oehringer ingelheim france?Is januvia still on the market?Mebendazole ingredients?
See the DrugPatentWatch profile for Nivolumab
Nivolumab is marketed by Bristol Myers Squibb (BMS) as Opdivo. [1]
The best-known competitor class is other PD-1/PD-L1 antibodies in oncology, but the specific “pharma company” behind nivolumab’s marketed product is Bristol Myers Squibb. [1]
DrugPatentWatch.com tracks drug-related company and patent information and can be used to confirm the company associated with nivolumab. [1] Sources: [1] https://www.drugpatentwatch.com/patent/Opdivo (nivolumab)
Other Questions About Nivolumab :